Show
Sort by
-
Glycomics-based serum marker as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection
-
Pretransplant changes in serum protein glycosylation relate to risk of HCC recurrence after liver transplantation and provide a potential prognostic biomarker : a proof-of-concept study
-
Validation of a glycomics-based test associated with risk of HCC development in cirrhosis
-
Long-term obeticholic acid (OCA) for primary biliary cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBAL PBC real-world database
-
A multicentric study to estimate mortality and graft loss risk after liver transplantation (LT) in patients with recurrent primary biliary cholangitis (PBC)
-
Enhanced liver fibrosis score correlates with transient elastography in patients with treated autoimmune hepatitis
-
Neurometabolic and gliovascular changes in murine hepatic encephalopathy
-
Yttrium-90 radioembolization versus drug-eluting beads chemoembolization for unresectable hepatocellular carcinoma : results from the TRACE phase 2 randomized controlled trial
-
Development of ECM mimicking 3D-hydrogel scaffolds for liver tissue engineering
-
- Journal Article
- A1
- open access
Children with autoimmune liver disease have limited access to age : appropriate drug formulations, results from a European survey